Sapien 3 Embolization From Ventricle to Aorta in the Setting of Noncalcified Aortic Regurgitation

Robin Le Ruz; Julien Plessis; Guillaume Guimbretiere; Jean-Christian Roussel; Pierre-Guillaume Piriou; Caroline Cueff; Blandine Maurel; Vincent Letocart; Thibaut Manigold

doi:10.1016/j.jaccas.2020.11.024

Sapien 3 Embolization From Ventricle to Aorta in the Setting of Noncalcified Aortic Regurgitation

JACC Case Rep. 2021 Jan 13;3(1):64-68. doi: 10.1016/j.jaccas.2020.11.024. eCollection 2021 Jan.

Authors

Robin Le Ruz¹, Julien Plessis¹, Guillaume Guimbretiere², Jean-Christian Roussel², Pierre-Guillaume Piriou¹, Caroline Cueff¹, Blandine Maurel^{3

4}, Vincent Letocart¹, Thibaut Manigold¹

Affiliations

¹ Cardiology Service, Thoracic Institute, Nantes University Hospital, Nantes, France.
² Cardiothoracic Surgery Service, Thoracic Institute, Nantes University Hospital, Nantes, France.
³ Vascular Surgery Service, Thoracic Institute, Nantes University Hospital, Nantes, France.
⁴ Pathophysiology of Bone Resorption Laboratory (Inserm-UN UMR-957), Nantes, France.

Abstract

Transcatheter aortic valve replacement is currently used off-label for noncalcified aortic valve regurgitation and therefore is restricted to selected cases. In this setting we describe a rare complication of Sapien 3 (Edwards Lifesciences, Irvine, California) embolization from the left ventricle to the descending aorta. Given their technical challenges, such procedures require specific considerations and management. (Level of Difficulty: Advanced.).

Keywords: AR, aortic regurgitation; BE, balloon-expandable; LV, left ventricular; SE, self-expandable; device embolization; native pure aortic regurgitation; transcatheter aortic valve replacement.

Publication types

Case Reports